Nishijo et al. Chem. Pharm. Bull. 33: 2648-2653, 1985. |
Basak. Asian J. Chem. 5(2):316-318, 1993. |
Broughton and Strong, Clin. Chem. 22:726-732 (1976). |
Butler, J. Immunol. Meth. 7:1-24 (1975). |
Cuatrecasas, J. Biol. Chem. 245:3059 (1970). |
Epinette, et al., Journal of the American Academy of Dermatology 17(6):962-71 (1987). |
Galfre, et al. (1981) Preparation of monoclonal antibodies: strategies and procedures, Methods Enzymol. 73:3-46. |
Grabarek, et al., (1990) Zero-length crosslinking procedure with the use of active esters, Anal. Biochem. 185:131-135. |
Kohler and Milstein, Nature 265:495-497, 1975. |
Langman, et al., Therapeutic Drug Monitoring (1994) 16:602-607. |
Lee, et al., Pharmaceutical Research 7(2):161-166 (1990). |
Lymphocyte Hybridomas, ed. Melchers, et al. Springer-Verlag (New York 1978). |
Nature 266:495 (1977). |
Nelson, et al., Journal of Medicinal Chemistry 33(2):833-838 (1990). |
Playfair, et al., Br. Med. Bull. 30:24-31 (1974). |
Science 208:693 (1980). |
Yalow, et al., J. Clin. Invest. 39:1157 (1960). |
Basak, D., Interaction of Transition Metal Ions with some Biologically Active Ligands, Asian Journal of Chemistry, vol. 5, No. 2 (1993), 316-318. |
Shaw, et al., Mycophenolic Acid: Measurement and Relationship to Pharmacologic Effects, Therapeutic Drug Monitoring, vol. 17, No. 16, pp. 685-689, 1995. |
Erre, L., et al. Interaction of Metal Ions With Humic-Like Models-X. Synthesis, Spectral Properties and Thermal Decomposition of Copper (II) Methoxy- And Dimethoxy-Benzoates, Polyhedron, vol. 6, No. 10, pp. 1869-1874, 1987. |
Pethe, L.D., et al., A Simple Continuous Titration Technique for Determining pK Values of Protonated Ligands, Indian Journal of Chemistry, vol. 15A, Nov., 1977, pp. 998-1001. |
Lucanska, B., et al., Thermal Analysis of some Copper p-methoxybenzoate complexes, Zb. Celostatnej Konf. Term. Anal., 8.sup.th (1979) 255-8, Abstract. |
Carey, "Organic Chemistry", McGraw Hill, Inc., NY NY, 1.sup.st ed., 1987, pp. 609 & 994-995. |
Heathcock, et al., "Introduction to Organic Chemistry", MacMillan Pub Co., NY NY, 3.sup.rd ed, 1985 pp. 493 & 814. |
Nerli et al., Arch Int Physiol Biochim Biophys (1994) 102(1): 5-8. |
Seth et al., Clin Chem (1975) 21 (10): 1406-1413. |
Wu, J.C., Perspectives in Drug Discovery and Design, 2 (1994) p. 185-204. |
Allison et al., "Mechanisms of Action of Mycophenolic Acid," Annals of New York Academy of Science, vol. 696, pp. 63-87, 1993. |
Haley et al., "Analytical Performance of an Emil.RTM. Assay for Mycophenolic Acid in Plasma," Clinical Chemistry, 43(6):S209 Abstract No. 474, Jun. 1997. |
Holt et al., "Monitoring New Immunosuppasive Agents: Are the Methods Adequate?" Drug Metabol. Drug Inter. 14(1): 5-15, 1997. |
Langman et al., "Blood Distribution of Mycophenolic Acid," Therapeutic Drug Monitoring, 16: 602-607, Dec. 1994. |
Nowak et al., "Mycophenolic Acid Binding to Human Serum Albumin: Characterization and Relations to Pharmacodynamics," Clin. Chem. 41(7): 1011-1017, 1995. |
Shaw et al., "Mycophenolic Acid: Measurement and Relationship to Pharmacologic Effects," Therap. Drug Monitoring 17: 685-689, 1995. |
Tsina et al., "High-Performance Liquid Chromatographic Method for the Determination of Mycophenolate Mofetel . . . " J. Chromatog. B 681: 347-353, Jun. 1996. |
Yatscoff et al, "Pharmacodynamic Monitoring of Immunosuppressive Drugs," Transplantation Proceedings, 28(6): 3013-3015, Dec. 1996. |